Probabilistic classification and gambling in patients with schizophrenia receiving medication: Comparison of risperidone, olanzapine, clozapine and typical antipsychotics

Psychopharmacology

Volumn 222, Issue 1, 2012, Pages 173-183

  Wasserman, James I ^a   Barry, Rebecca J ^a   Bradford, Lisa ^a   Delva, Nicholas J ^a,b   Beninger, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Declarative memory; Dopamine; Striatum

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DECLARATIVE MEMORY; FEMALE; HUMAN; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NEGATIVE SYNDROME; NON DECLARATIVE MEMORY; PATHOLOGICAL GAMBLING; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PROBABILISTIC CLASSIFICATION LEARNING; QUESTIONNAIRE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DECISION MAKING; FEMALE; GAMBLING; HUMANS; LEARNING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA;

EID: 84861850052     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2634-4     Document Type: Article

References (52)

1. Allain H, Lieury A, Thomas V, Reymann JM, Gandon JM, Belliard S (1995) Explicit and procedural memory in Parkinson's disease. Biomed Pharmacother 49:179-186
2. Aron AR, Shohamy D, Clark J, Myers C, Gluck MA, Poldrack RA (2004) Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J Neurophysiol 92:1144-1152 (Pubitemid 38931973)
3. Bechara A (2004) The role of emotion in decision making: evidence from neurological patients with orbitofrontal damage. Brain Cognit 55:30-40
4. Bechara A, Damasio H, Tranel D (1997) Deciding advantageously before knowing the advantageous strategy. Science (Wash) 275:1293-1295 (Pubitemid 27114154)
5. Bechara A, Damasio H, Damasio A, Lee G (1999) Different contributions of the human amygdala and ventromedial prefrontal cortex to decision making. J Neurosci 19:5473-5481 (Pubitemid 29300212)
6. Bechara A, Tranel D, Damasio H (2000) Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. J Neurol 123:2189-2202
7. Bedard MA, Scherer H, Stip E, Cohen H, Rodriguez JP, Richer F (2000) Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics. Brain Cogn 43:31-39
8. Beninger RJ, Wasserman J, Zanibbi K, Charbonneau D, Mangels J, Beninger B (2003) Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation. Schizophr Res 61:281-292 (Pubitemid 36513941)
9. Beninger RJ, Baker TW, Florczynski MM, Banasikowski TJ (2010) Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Neurotox Res 18:229-243
10. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA et al (2000) Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatr 157:549-559 (Pubitemid 30191193)
11. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ (2005) Decision-making impairments in patients with pathological gambling. Psychiatr Res 133:91-99 (Pubitemid 40215475)
12. Charbonneau D, Riopelle RJ, Beninger RJ (1996) Impaired incentive learning in treated Parkinson's disease. Can J Neurol Sci 23:271-278 (Pubitemid 26403106)
13. Ernst M, Bolla K, Mouratidis M, Contoreggi C, Matochik JA, Kurian V, Cadet JL, Kimes AS, London ED (2002) Decision making in a risk-taking task: a PET study. Neuropsychopharmacol 26:682-691 (Pubitemid 34260987)
14. Fischman MW, Schuster CR (1979) The effects of chlorpromazine and pentobarbital on behavior maintained by electric shock or point loss avoidance in humans. Psychopharmacology (Berlin) 66:3-11 (Pubitemid 10165856)
15. Fischman MW, Smith RC, Schuster CR (1976) Effects of chlorpromazine on avoidance and escape responding in humans. Pharmacol Biochem Behav 4:111-114
16. Fletcher PC, Happe F, Frith U, Baker SC, Dolan RJ, Frackowiak RS, Frith CD (1995) Other minds in the brain: a functional imaging study of "theory of mind" in story comprehension. Cognition 57:109-128
17. Folstein MF, Folstein SE, McHugh SE (1975) "Mini-Mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198
18. Fujimura M, Hashimoto K, Yamagami K (2000) The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Life Sci 67:2865-2872
19. Fukui H, Murai T, Fukuyama H, Hayashi T, Hanakawa T (2005) Functional activity related to risk anticipation during performance of the Iowa gambling task. NeuroImage 24:253-259 (Pubitemid 39611046)
20. Gluck MA, Bower GH (1988) From conditioning to category learning: an adaptive network model. J Exp Psychol 1:25-30
21. Gomar JJ, Pomarol-Clotet E, Sarro S, Salvador R, Myers CE, McKenna PJ (2011) Procedureal learning in schizophrenia: reconciling the discrepant finding. Biol Psychiatr 69:49-54
22. Harris MS, Wiseman CL, Reilly JL, Keshaven MS, Sweeney JA (2009) Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia. Neuropsychopharmacol 34:468-476
23. Haw C, Stubbs J (2007) Off-label use of antipsychotics: are we mad? Expert Opin Drug Saf 6:533-545 (Pubitemid 351308212)
24. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N (1989) Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci 9:582-587 (Pubitemid 19069503)
25. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H (2009) Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand 119:365-374
26. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276 (Pubitemid 18039085)
27. Knowlton BJ, Mangels JA, Squire LR (1996) A neostriatal habit learning system in humans. Science (Wash) 273:1399-1402 (Pubitemid 26296530)
28. Koeing O, Tomas-Anterion C, Laurent B (1999) Procedural learning in Parkinson's disease: intact and impaired cognitive components. Neuropsychologia 37:1103-1109
29. Kumari V, Gray JA, Corr PJ, Mulligan OF, Cotter PA, Checkley SA (1997) Effects of D-amphatamine and haloperidol on procedural learning in man. Psychopharmacology 129:271-276 (Pubitemid 27085398)
30. Kumari V, Gray JA, Honey GD, Soni W, Bullmore E, Williams SC, Ng VW, Vythelingham GN, Simmons A, Suckling J, Corr PJ, Sharma T (2002) Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res 57:97-107
31. Leeson VC, RobbinsTW,Matheson E, Hutton S, Ron A, Barnes T, Joyce EM (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatr 66:586-593
32. Marder S, Fenton W (2004) Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 72:5-9 (Pubitemid 39452900)
33. Milner B, Squire LR, Kandel ER (1998) Cognitive neuroscience and the study of memory. Neuron 20:445-468 (Pubitemid 28153077)
34. Paquet F, Soucy JP, Stip E, Levesque M, Elie A, Bedard MA (2004) Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia. J Neuropsych Clin N 16:47-56 (Pubitemid 38233363)
35. Purdon SE, Woodward N, Lindborg SR (2003) Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology 169:390-397 (Pubitemid 37255528)
36. Purdon SE, Waldie B, Woodward ND, Wilman AH, Tibbo P (2011) Procedural learning in first episode schizophrenia investigated with functional magnetic resonance imaging. Neuropsychology 25:147-158
37. Reiss JP, Campbell DW, Leslie WD, Paulus MP, Ryner LN, Polimeni JO, Foot BJ, Sareen J (2006) Deficit in schizophrenia to recruit the striatum in implicit learning: a functional magnetic resonance imaging investigation. Schizophr Res 87:127-137 (Pubitemid 44428109)
38. Rémillard S, Pourcher E, Cohen H (2010) Long-term skill proceduralization in schizophrenia. J Int Neuropsychol Soc 16:148-156
39. Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058-1066 (Pubitemid 24377799)
40. Saint-Cyr JA, Taylor AE, Lang AE (1988) Procedural learning and neostriatal dysfunction in man. Brain 111:941-959
41. Savina I, Beninger RJ (2007) Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications. Schizophr Res 94:128-138 (Pubitemid 47031590)
42. Scherer H, Bedard M, Stip E, Paquet F, Richer F, Beriault M et al (2004) Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments. Cogn Behav Neurol 17:32-40 (Pubitemid 38332699)
43. Seger CA, Cincotta CM (2005) The roles of the caudate nucleus in human classification learning. J Neurosci 25:2941-2951 (Pubitemid 40389252)
44. Squire LR (1986) Mechanisms of memory. Science (Wash) 4758:1612-1619
45. Squire LR, Knowlton BJ (2000) The medial temporal lobe, the hippocampus, and the memory systems of the brain. In: Gazzaniga MS (ed) The new cognitive neurosciences. MIT Press, Cambridge, MA, pp 765-779
46. Stevens A, Schwarz J, Schwarz B (2002) Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics. Psychopharmacology 160:299-306
47. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW (2000) Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38:596-612 (Pubitemid 30109440)
48. Tranel D, Bechara A, Damasio AR (1999) Decision making and the somatic marker hypothesis. In: Gazzinaga MS (ed) The new cognitive neuroscience. MIT Press, Cambridge MA, pp 1115-1131
49. Wan W, Ennulat DJ, Cohen BM (1995) Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res 668:95-104
50. Weiden PJ (2007) EPS profiles: the atypical antipsychotics are not all the same. J Psychiatr Pract 13:13-24
51. Westerink BH (2002) Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? Eur J Pharmacol 455:1-18
52. Zedkova L, Woodward ND, Harding I, Tibbo PG, Purdon SE (2006) Procedural learning in schizophrenia investigated with functional magnetic resonance imaging. Schizophr Res 88:198-207 (Pubitemid 44693233)